Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte intercellular adhesion proteins, primarily represented by the desmoglein family (DSG1 and DSG3), are essential transmembrane glycoproteins that form the core of desmosomes, the specialized junctions responsible for strong cell-cell adhesion in the epidermis. These proteins belong to the cadherin superfamily and mediate calcium-dependent adhesion between adjacent keratinocytes, ensuring the structural integrity of the skin and mucous membranes. In autoimmune diseases such as pemphigus vulgaris and pemphigus foliaceus, autoantibodies target these proteins, leading to the loss of adhesion (acantholysis) and the formation of life-threatening blisters. Therapeutic strategies focus on reducing the levels of these pathogenic autoantibodies through B-cell depletion (e.g., rituximab) or FcRn inhibition (e.g., efgartigimod), as well as experimental approaches like chimeric autoantibody receptor (CAAR) T-cell therapy designed to specifically eliminate autoreactive B cells.
B-cell depletion, inhibition of neonatal Fc receptor (FcRn) to increase IgG clearance, systemic immunosuppression, and targeted chimeric autoantibody receptor T-cell therapy.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3) (DSG1/3).